Arginine Adjunctive Therapy in Active Tuberculosis

Table 1

Clinical and laboratory findings in arginine and placebo group before treatment.

Sign and symptom	Group		value
	Arginine; (%)	Placebo; (%)
Age (mean ± SD)	51.9 ± 22.8	52.3 ± 21.7	0.943
Gender
Male	15 (46.9)	16 (51.6)	0.704
Female	17 (53.1)	15 (48.4)
Resident
Rural	14 (43.7)	12 (38.7)	0.682
Urban	18 (56.3)	19 (61.3)
Constitutional symptoms	30 (93.8)	29 (93.6)	0.976
Cough	29 (90.6)	28 (90.3)	0.968
BMI < 18.5	15 (46.9)	14 (45.2)	0.889
Tuberculin test >10 mm	27 (84.4)	26 (83.8)	0.96
Sputum smear >1+	13 (40.6)	13 (41.9)	0.912
Anemia^*	17 (53.1)	16 (51.6)	0.904
↑ ESR^** mm/h	28 (87.5)	29 (93.6)	0.412
↑ CRP^***	24 (75)	22 (71)	0.719

Hg <13 g/dl in men and Hg <12 g/dl in women.
^**The normal range (Westergren method) for males is 0–15 mm/h and for females is 0–20 mm/h.
^***CRP >10 mg/L.